The Grand Winner
March 31, 2023
Which Innovation Award technology did readers vote as our Grand Winner?
1 min read
Mar
To Be Precise
March 30, 2023
With more and better data comes new advances, specifically in our knowledge of individual genetics. Here, Neil Ward, VP PacBio, EMEA, explains how pharmacogenomics research will accelerate precision medicine initiatives.
3 min read
Stem Cells: The Next (Re)generation
March 29, 2023
Through its Phase I/IIb EXCELLENT clinical trial, CellProthera, a France-based biotechnology research company focusing on cardiac tissue regeneration, is demonstrating the safety and efficacy of a cell therapy approach to regenerating tissue following myocardial infarction. Here, CEO Matthieu de Kalbermatten shares his ambition to fulfil the promise of stem cell research.
4 min read
Funding Pharma’s All-Female Leaders
March 28, 2023
In Britain and around the world, the investment ecosystem dominated by males needs an urgent shake up.
4 min read
Digitally Decentralized by Design
March 23, 2023
Through a partnership with software developer Medable, Syneos Health aims to decentralize clinical trials and make them more accessible and personalized.
3 min read
The World’s Most Studied Disease
March 22, 2023
Breast cancer was researched more than any other disease, including COVID-19, in 2022. We asked Phesi CEO Gen Li what helps and what hinders the breast cancer research process.
5 min read
Discovery & Development
Drug Discovery
Drug Delivery
Formulation
Small Molecules
Drug Discovery
Research News
Drug Delivery
Formulation
Small Molecules
Flying with the FALCON
March 21, 2023
An inside view on a platform that could help take RNA therapeutics to the next level of delivery
5 min read
Teaching Old Vaccines New Tricks
March 20, 2023
Why is self-amplifying mRNA gaining more and more attention in the vaccine space?
8 min read
Memorable Mushrooms
March 17, 2023
These fungi have some real nerve (developing properties)
2 min read
Broad Strokes
March 16, 2023
Universal flu vaccines have been a holy grail for many years – and Centivax believes it could be onto a breakthrough with its broad spectrum vaccine approach to influenza and other pathogens
7 min read
Browse by Topics
Interview
Drug Discovery
Development & Clinical
Formulation
Drug Delivery
Bioprocessing
Small Molecules
Cell & Gene
Facilities & Equipment
Outsourcing
Packaging
Supply Chain
Regulation & Standards
Industry News
Research News
Sitting Down With
Innovation Awards
Business & Trends
Technology & Manufacturing
Biopharma
Future of Pharma
Latest
Blog